All Programs

Use the tool below to view all available Rheumatology Academy Series

Key Advances in Rheumatology at CCR East 2026
Key Advances in Rheumatology at CCR East 2026
Living Rheum
Key Advances in Rheumatology at CCR East 2026
Louis Bessette MD, FRCP(C), MSc
- Louis Bessette MD, FRCP(C), MSc
The Cardiovascular Dimension of Psoriatic Arthritis
The Cardiovascular Dimension of Psoriatic Arthritis
Living Rheum
The Cardiovascular Dimension of Psoriatic Arthritis
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Living Rheum
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Measuring What Matters in Psoriatic Arthritis
Measuring What Matters in Psoriatic Arthritis
Living Rheum
Measuring What Matters in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Living Rheum
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Diagnosing Psoriatic Arthritis: A Real-World Case
Diagnosing Psoriatic Arthritis: A Real-World Case
Living Rheum
Diagnosing Psoriatic Arthritis: A Real-World Case
Lawrence H. Brent
- Lawrence H. Brent
Modern Approaches to Psoriatic Arthritis Management
Modern Approaches to Psoriatic Arthritis Management
Living Rheum
Modern Approaches to Psoriatic Arthritis Management
Lawrence H. Brent
- Lawrence H. Brent
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Living Rheum
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Living Rheum
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living Rheum
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living Rheum
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Ryan Quigley; Luigi Adamo, MD, PhD
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
- Ryan Quigley

All Programs

Popular

CONTACT US

(866) 423-7849

CONTACT US

(866) 423-7849

All Programs

Popular

Title